Halogen Bonds in Ligand–Protein Systems: Molecular Orbital Theory for Drug Design
Author(s) -
Enrico Margiotta,
Stephanie C. C. van der Lubbe,
Lucas de Azevedo Santos,
Gábor Paragi,
Stefano Moro,
F. Matthias Bickelhaupt,
Célia Fonseca Guerra
Publication year - 2020
Publication title -
journal of chemical information and modeling
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 160
eISSN - 1549-960X
pISSN - 1549-9596
DOI - 10.1021/acs.jcim.9b00946
Subject(s) - halogen bond , hydrogen bond , chemistry , steric effects , computational chemistry , molecular orbital , natural bond orbital , ligand (biochemistry) , halogen , acceptor , combinatorial chemistry , chemical physics , stereochemistry , density functional theory , molecule , organic chemistry , receptor , physics , quantum mechanics , biochemistry , alkyl
Halogen bonds are highly important in medicinal chemistry as halogenation of drugs, generally, improves both selectivity and efficacy toward protein active sites. However, accurate modeling of halogen bond interactions remains a challenge, since a thorough theoretical investigation of the bonding mechanism, focusing on the realistic complexity of drug-receptor systems, is lacking. Our systematic quantum-chemical study on ligand/peptide-like systems reveals that halogen bonding is driven by the same bonding interactions as hydrogen bonding. Besides the electrostatic and the dispersion interactions, our bonding analyses, based on quantitative Kohn-Sham molecular orbital theory together with energy decomposition analysis, reveal that donor-acceptor interactions and steric repulsion between the occupied orbitals of the halogenated ligand and the protein need to be considered more carefully within the drug design process.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom